Continuation of therapeutic dose heparin for critically ill patients with COVID-19
Intensive Care Med
.
2023 Jul;49(7):873-875.
doi: 10.1007/s00134-023-07095-8.
Epub 2023 May 31.
Authors
Charlotte A Bradbury
1
2
,
Patrick R Lawler
3
4
,
Bryan J McVerry
5
,
Ryan Zarychanski
6
;
REMAP-C. A. P. Investigators
Collaborators
REMAP-C. A. P. Investigators
:
Farah Al-Beidh
,
Derek C Angus
,
Yaseen M Arabi
,
Diptesh Aryal
,
Djillali Annane
,
Abi Beane
,
Lindsay R Berry
,
Scott Berry
,
Zahra Bhimani
,
Shailesh Bihari
,
Marc J M Bonten
,
Charlotte A Bradbury
,
Frank M Brunkhorst
,
Meredith Buxton
,
Adrian Buzgau
,
Marc Carrier
,
Allen C Cheng
,
Matthew Cove
,
Lennie P G Derde
,
Michelle A Detry
,
Lise J Estcourt
,
Dean A Fergusson
,
Mark Fitzgerald
,
Robert A Fowler
,
Timothy D Girard
,
Ewan C Goligher
,
Herman Goossens
,
Anthony C Gordon
,
Cameron Green
,
Rashan Haniffa
,
Alisa M Higgins
,
Thomas Hills
,
David T Huang
,
Christopher M Horvat
,
Beverley J Hunt
,
Nao Ichihara
,
Devachandran Jayakumar
,
Anand Kumar
,
Michael A Laffan
,
Francois Lamontagne
,
Patrick R Lawler
,
Helen L Leavis
,
Roger J Lewis
,
Kelsey M Linstrum
,
Edward Litton
,
Elizabeth Lorenzi
,
Sylvain A Lother
,
John C Marshall
,
Colin J McArthur
,
Daniel F McAuley
,
Anna McGlothlin
,
Shay P McGuinness
,
Saskia Middeldorp
,
Srinivas Murthy
,
Zoe McQuilten
,
Bryan J McVerry
,
Paul R Mouncey
,
Matthew D Neal
,
Alistair D Nichol
,
Rachael L Parke
,
Jane C Parker
,
Asad Patanwala
,
Luis Reyes
,
Kathryn M Rowan
,
Hiroki Saito
,
Marlene S Santos
,
Christina T Saunders
,
Roger E G Schutgens
,
Ary Serpa-Neto
,
Christopher W Seymour
,
Manu Shankar-Hari
,
Vanessa Singh
,
Simon J Stanworth
,
Timo Tolppa
,
Alexis F Turgeon
,
Anne M Turner
,
Wilma van Bentum-Puijk
,
Frank L van de Veerdonk
,
Steve A Webb
Affiliations
1
University of Bristol, Bristol, UK.
[email protected]
.
2
Bristol Haematology and Oncology Centre, Horfield Road, Bristol, BS2 8ED, UK.
[email protected]
.
3
Peter Munk Cardiac Centre at University Health Network, Toronto, Canada.
4
University of Toronto, Toronto, Canada.
5
University of Pittsburgh, Pittsburgh, USA.
6
University of Manitoba, Winnipeg, Canada.
PMID:
37256341
PMCID:
PMC10231279
DOI:
10.1007/s00134-023-07095-8
No abstract available
Publication types
Letter
MeSH terms
Anticoagulants / therapeutic use
COVID-19*
Critical Illness / therapy
Heparin* / therapeutic use
Heparin, Low-Molecular-Weight
Humans
SARS-CoV-2
Substances
Heparin
Anticoagulants
Heparin, Low-Molecular-Weight